Use, Accuracy, and Implications for Patient Management of [18F]-2-Fluorodeoxyglucose-Positron Emission/Computerized Tomography for Head and Neck Tumors
โ Scribed by Adam M. Zanation; David K. Sutton; Marion E. Couch; Mark C. Weissler; William W. Shockley; Carol G. Shores
- Book ID
- 110087708
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 191 KB
- Volume
- 115
- Category
- Article
- ISSN
- 0023-852X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Background: [f-18]fluorodeoxyglucose (fdg)-positron emission tomography (pet) can measure the metabolic activity of tissues; fdg-pet may be able to predict response to chemotherapy by identifying changes in tumor metabolism. measurement of response to treatment may help improve survival in the m
## Abstract ## BACKGROUND Patients with recurrent oral squamous cell carcinoma (OSCC) have a dismal prognosis and represent a therapeutic challenge. A positron emission tomography (PET) scan with [^18^F]โ2โfluorodeoxyglucose ([^18^F]FDG) can improve early cancer detection. The current study evalua
## BACKGROUND. Second primary tumors are a leading cause of death among patients with head and neck cancer; therefore, early detection of these tumors is necessary. In the current study, the authors aimed to evaluate the diagnostic capacity of 18 F-fluorodeoxyglucose dual-head positron emission t